Evidence map›Paper›PMID 39555736›Full record

ArticleCancer science2025

NETosis in pulmonary pleomorphic carcinoma.

Hajime Oi, Tetsuro Taki, Takashi Kuroe, Naoya Sakamoto, Shingo Sakashita, Motohiro Kojima, Eri Sugiyama, Shigeki Umemura, Tetsuya Sakai, Hiroki Izumi and 7 more

Abstract read
In one paragraph

Article in Cancer science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Hajime OiDepartment of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan.
Tetsuro TakiDepartment of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan.ORCID https://orcid.org/0000-0001-8654-6896
Takashi KuroeDepartment of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan.ORCID https://orcid.org/0000-0002-2366-2467
Naoya SakamotoDepartment of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan.ORCID https://orcid.org/0000-0001-6273-0189
Shingo SakashitaDepartment of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan.ORCID https://orcid.org/0000-0003-1133-3313
Motohiro KojimaDepartment of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan.ORCID https://orcid.org/0000-0002-6150-6545
Eri SugiyamaDepartment of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Shigeki UmemuraDepartment of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Tetsuya SakaiDepartment of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Hiroki IzumiDepartment of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Yoshitaka ZenkeDepartment of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.ORCID https://orcid.org/0000-0002-7641-9065
Shingo MatsumotoDepartment of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Kiyotaka YohDepartment of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.ORCID https://orcid.org/0000-0001-6928-357X
Makoto IshiiDepartment of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Masahiro TsuboiDepartment of Thoracic Surgery, National Cancer Center Hospital East, Kashiwa, Japan.
Koichi GotoDepartment of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.ORCID https://orcid.org/0000-0002-3023-2510
Genichiro IshiiDepartment of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan.ORCID https://orcid.org/0000-0001-8637-3323

Funding

Japan Society for the Promotion of Science 21H02931
6 · The paper itself

Abstract

Pulmonary pleomorphic carcinoma (PC) is a rare non-small-cell lung carcinoma (NSCLC) with a poor prognosis, characterized by tumor necrosis (TN). NETosis is a form of neutrophil-specific cell death, which is morphologically characterized by prominent neutrophil infiltration and cell detritus in the necrotic foci. Seventy-six patients with pulmonary PC who underwent complete resection were enrolled. Tumor necrosis was evaluated using digitally scanned resected specimens. The regions of NETosis were quantified using citrullinated histone H3 (citH3)- and myeloperoxidase-positive regions. We examined the association between the NETosis area and the prognostic outcomes and assessed the correlation between the NETosis area and systemic inflammation. Tumor necrosis was observed in 70 patients (92%). In all the cases, the TN region was accompanied by a citH3-positive region. The patients with high NETosis area (n = 54) had significantly shorter overall survival than those with low NETosis area (n = 16) (p = 0.013). Furthermore, a high NETosis area was an independent poor prognostic factor in the multivariate analyses. Systemic inflammatory markers, including C-reactive protein (CRP), CRP-to-albumin ratio, and neutrophil-to-lymphocyte ratio, were significantly higher in patients with high NETosis area than in those with low NETosis area. Furthermore, the levels of these inflammatory markers were significantly decreased postsurgery. This study shows that in surgically resected pulmonary PC, patients with high NETosis areas have higher systemic inflammation and worse prognosis.

Indexed as

Carcinoma, Non-Small-Cell LungExtracellular TrapsLung NeoplasmsAdultAgedAged, 80 and overC-Reactive ProteinFemaleHistonesHumansInflammationMaleMiddle AgedNecrosisNeutrophilsPeroxidaseC-Reactive ProteinHistonesPeroxidasedirty necrosisNETNETosispulmonary pleomorphic carcinomasystemic inflammation

Identifiers

PMID39555736
PMCPMC11786310

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.